tradingkey.logo

Oncolytics Biotech Inc <ONC.TO> expected to post a loss of 10 cents a share - Earnings Preview

ReutersMay 12, 2025 8:12 PM
  • Oncolytics Biotech Inc ONC.TO is expected to show no change in quarterly revenue when it reports results on May 14 for the period ending March 31 2025

  • ​LSEG's mean analyst estimate for Oncolytics Biotech Inc is for a loss of 10 cents per share.

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 4 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."

  • The mean earnings estimate of analysts was unchanged in the last three months. ​

  • Wall Street's median 12-month price target for Oncolytics Biotech Inc is C$5.00​, above​ its last closing price of $0.52. ​​​

Previous quarterly performance (using preferred earnings measure in Canadian dollars). ​

QUARTER ENDING

STARMINESMARTESTIMATE®

LSEG IBES ESTIMATE

ACTUAL

BEAT, MET, MISSED

SURPRISE %

Dec. 31 2024

-0.13

-0.12

-0.10

Beat

18.2

Sep. 30 2024

-0.10

-0.10

-0.12

Missed

-17.8

Jun. 30 2024

-0.10

-0.10

-0.10

Met

0.6​

Mar. 31 2024

-0.11

-0.11

-0.09

Beat

16.3

​​Dec. 31 2023

-0.15

-0.15

-0.05

Beat

66.1

Sep. 30 2023

-0.10

-0.10

-0.14

Missed

-34.6​

Jun. 30 2023

-0.11

-0.11

-0.12

Missed

-6.3

Mar. 31 2023

-0.14

-0.13

-0.10

Beat

24.5

This summary was machine generated May 12 at 20:12 GMT. All figures in Canadian dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI